Significant Ownership of PFM Health Sciences, LP

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for PFM Health Sciences, LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Darren Mooney - Darren Mooney, Authorized Signatory
Manager location
San Francisco, CA

Follow Filing Activity

Follow PFM Health Sciences, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Significant Ownership of PFM Health Sciences, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OM Outset Medical, Inc. Common Stock, par $0.001 per share (the "Shares") 2.9% $1,969,253 -$90,780,747 530,796 -98% PFM Health Sciences, LP 31 Dec 2025
HOWL Werewolf Therapeutics, Inc. Common stock, par value $0.0001 per share (the "Shares") 0.9% $437,210 -$2,729,747 401,110 -86% PFM Health Sciences, LP 30 Jun 2025
PMVP PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") 0% $0 -$4,160,447 0 -100% PFM Health Sciences, LP 30 Jun 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share (the "Shares") 0% $0 0 PFM Health Sciences, LP 31 Dec 2024

Schedules 13D/G Reported by PFM Health Sciences, LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .